The effectiveness and risks of long-term opioid therapy for chronic pain: A systematic review for a national institutes of health pathways to prevention workshop

Annals of Internal Medicine

Volumn 162, Issue 4, 2015, Pages 276-286

  Chou, Roger ^a   Turner, Judith A ^b   Devine, Emily B ^c   Hansen, Ryan N ^c   Sullivan, Sean D ^c   Blazina, Ian ^a   Dana, Tracy ^a   Bougatsos, Christina ^a   Deyo, Richard A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; PLACEBO; NARCOTIC ANALGESIC AGENT;

ANALGESIA; CHRONIC PAIN; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MISUSE; DRUG OVERDOSE; FRACTURE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; META ANALYSIS (TOPIC); NATIONAL HEALTH ORGANIZATION; OBSERVATIONAL STUDY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; SUBSTANCE USE; SUDDEN CARDIAC DEATH; SYSTEMATIC REVIEW; DRUG ADMINISTRATION; FRACTURES, BONE; MYOCARDIAL INFARCTION; OPIOID-RELATED DISORDERS; RISK FACTOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

ANALGESICS, OPIOID; CHRONIC PAIN; DRUG ADMINISTRATION SCHEDULE; DRUG OVERDOSE; FRACTURES, BONE; HUMANS; MYOCARDIAL INFARCTION; OPIOID-RELATED DISORDERS; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 84923158714     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M14-2559     Document Type: Review

References (78)

1. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl. 1986;3:S1-226. [PMID: 3461421]
2. Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Pr; 2011.
3. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008;138:440-9. [PMID: 18547726] doi: 10.1016/j.pain.2008.04.027
4. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166-75. [PMID: 19718704] doi: 10.1002/pds.1833
5. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006;7:225-35. [PMID: 16618466]
6. Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med. 2011;26:958-64. [PMID: 21347877] doi: 10.1007/s11606-011-1648-2
7. Deyo RA, Smith DH, Johnson ES, Tillotson CJ, Donovan M, Yang X, et al. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine (Phila Pa 1976). 2013;38:909-15. [PMID: 23459134] doi: 10.1097/BRS.0b013e3182830482
8. Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS). 1999-2009. National Admissions to Substance Abuse Treatment Services. DASIS Series: S-56. HHS publication no. (SMA) 11-4646. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011. Accessed at http://wwwdasis.samhsa.gov/teds09/TEDS2k9NWeb.pdf on 12 December 2014.
9. Center for Behavioral Health Statistics and Quality. The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012. Accessed at www.samhsa.gov/data/sites/default/files/DAWN096/DAWN096/SR096EDHighlights2010.pdf on 12 December 2014.
10. Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152:712-20. [PMID: 20513829] doi: 10.7326/0003-4819-152-11-201006010-00004
11. Warner M, Chen LH, Makuc DM, Anderson RN, Mininõ AM. Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief. 2011:1-8. [PMID: 22617462]
12. Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011; 305:1346-7. [PMID: 21467287] doi: 10.1001/jama.2011.369
13. Saunders KW, Dunn KM, Merrill JO, Sullivan M, Weisner C, Braden JB, et al. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med. 2010;25: 310-5. [PMID: 20049546] doi: 10.1007/s11606-009-1218-z
14. Rolita L, Spegman A, Tang X, Cronstein BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc. 2013;61:335-40. [PMID: 23452054] doi: 10.1111/jgs.12148
15. Centers for Disease Control and Prevention. Prescription Drug Overdose in the United States: Fact Sheet. Atlanta, GA: Centers for Disease Control and Prevention; 2014. Accessed at www.cdc.gov/homeandrecreationalsafety/overdose/facts.html on 12 December 2014.
16. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589-94. [PMID: 16717269]
17. Furlan A, Chaparro LE, Irvin E, Mailis-Gagnon A. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain. Pain Res Manag. 2011;16:337-51. [PMID: 22059206]
18. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113-30. [PMID: 19187889] doi: 10.1016/j.jpain.2008.10.008
19. American Pain Society, American Academy of Pain Medicine. Guideline for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain: Evidence Review. Chicago: American Pain Society; 2009. Accessed at www.americanpainsociety.org/uploads/pdfs/Opioid-Final-Evidence-Report.pdf on 12 December 2014.
20. Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik JG, et al. The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Evidence report/technology assessment no. 218. (Prepared by the Pacific Northwest Evidence-based Practice Center under contract no. 290-2012-00014-I). AHRQ publication no. 14-E005-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2014. Accessed at www.effectivehealthcare.ahrq.gov/ehc/products/557/1971/chronic-pain-opioid-treatment-report-141007.pdf on 12 December 2014.
21. Agency for Healthcare Research and Quality. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Effective Health Care Program. AHRQ publication no. 10(13)-EHC063-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2013. Accessed at www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid=318&pageaction=display product on 12 December 2014.
22. Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik J, et al. The effectiveness and risks of long-term opioid treatment of chronic pain. PROSPERO: International Prospective Register of Systematic Reviews. CRD42014007016. 2014. Accessed at www.crd.york.ac.uk/PROSPERO/display-record.asp?ID=CRD42014007016 on 12 December 2014.
23. Furlan AD, Pennick V, Bombardier C, van Tulder M; Editorial Board, Cochrane Back Review Group. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine (Phila Pa 1976). 2009;34:1929-41. [PMID: 19680101] doi: 10.1097/BRS.0b013e3181b1c99f
24. U.S. Preventive Services Task Force. Procedure Manual. AHRQ publication no. 08-05118-EF. Rockville, MD: U.S. Preventive Services Task Force; 2008. Accessed at www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm on 12 December 2014.
25. Agency for Healthcare Research and Quality. Methods Guide for Medical Test Reviews. Effective Health Care Program. Rockville, MD: Agency for Healthcare Research and Quality; 2010. Accessed at http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid=558&pageaction=displayproduct on 12 December 2014
26. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529-36. [PMID: 22007046] doi: 10.7326/0003-4819-155-8 -201110180-00009
27. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA. 2000;284:79-84. [PMID: 10872017]
28. Owens D, Lohr KN, Atkins D, Treadwell J, Reston J, Bass E, et al. Grading the strength of a body of evidence when assessing health care interventions for the Effective Health Care Program of the Agency for Healthcare Research and Quality: an update. In: Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Rockville, MD: Agency for Healthcare Research and Quality; 2011. Accessed at http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?productid=1752&pageaction=displayproduct on 12 December 2014.
29. Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription. Clin J Pain. 2014;30:557-64. [PMID: 24281273] doi: 10.1097/AJP.0000000000000021
30. Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Opioid use behaviors, mental health and pain-development of a typology of chronic pain patients. Drug Alcohol Depend. 2009; 104:34-42. [PMID: 19473786] doi: 10.1016/j.drugalcdep.2009.03.021
31. Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS, et al. Risk factors for drug dependence among outpatients on opioid therapy in a large US health-care system. Addiction. 2010;105:1776-82. [PMID: 20712819] doi: 10.1111/j.1360-0443.2010.03052.x
32. Compton PA, Wu SM, Schieffer B, Pham Q, Naliboff BD. Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage. 2008;36:383-95. [PMID: 18508231] doi: 10.1016/j.jpainsymman.2007.11.006
33. Cowan DT, Wilson-Barnett J, Griffiths P, Allan LG. A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med. 2003;4:340-51. [PMID: 14750910]
34. Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain. 2007;8:573-82. [PMID: 17499555]
35. Højsted J, Nielsen PR, Guldstrand SK, Frich L, Sjøgren P. Classification and identification of opioid addiction in chronic pain patients. Eur J Pain. 2010;14:1014-20. [PMID: 20494598] doi: 10.1016/j.ejpain.2010.04.006
36. Portenoy RK, Farrar JT, Backonja MM, Cleeland CS, Yang K, Friedman M, et al. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain. 2007;23:287-99. [PMID: 17449988]
37. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17:173-9. [PMID:11929502]
38. Saffier K, Colombo C, Brown D, Mundt MP, Fleming MF. Addiction Severity Index in a chronic pain sample receiving opioid therapy. J Subst Abuse Treat. 2007;33:303-11. [PMID: 17376639]
39. Schneider JP, Kirsh KL. Defining clinical issues around tolerance, hyperalgesia, and addiction: a quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice. J Opioid Manag. 2010;6:385-95. [PMID: 21268999]
40. Wasan AD, Butler SF, Budman SH, Fernandez K, Weiss RD, Greenfield SF, et al. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain. 2009;25:193-8. [PMID: 19333168] doi: 10.1097/AJP.0b013e318193a6c4
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013.
42. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85-92. [PMID: 20083827] doi: 10.7326/0003-4819-152-2-201001190-00006
43. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171:686-91. [PMID: 21482846] doi: 10.1001/archinternmed.2011.117
44. Li L, Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database. Am J Epidemiol. 2013;178:559-69. [PMID: 23639937] doi: 10.1093/aje/kwt013
45. Carman WJ, Su S, Cook SF, Wurzelmann JI, McAfee A. Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort. Pharmacoepidemiol Drug Saf. 2011;20:754-62. [PMID: 21567652] doi: 10.1002/pds.2131
46. Li L, Setoguchi S, Cabral H, Jick S. Opioid use for noncancer pain and risk of myocardial infarction amongst adults. J Intern Med. 2013; 273:511-26. [PMID: 23331508] doi: 10.1111/joim.12035
47. Gomes T, Redelmeier DA, Juurlink DN, Dhalla IA, Camacho X, Mamdani MM. Opioid dose and risk of road trauma in Canada: a population-based study. JAMA Intern Med. 2013;173:196-201. [PMID: 23318919] doi: 10.1001/2013.jamainternmed.733
48. Salzman RT, Roberts MS, Wild J, Fabian C, Reder RF, Goldenheim PD. Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control? J Pain Symptom Manage. 1999;18: 271-9. [PMID: 10534967]
49. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine (Phila Pa 1976). 1998;23:2591-600. [PMID: 9854758]
50. Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain. Spine (Phila Pa 1976). 2005;30: 2484-90. [PMID: 16284584]
51. Wild JE, Grond S, Kuperwasser B, Gilbert J, McCann B, Lange B, et al. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain. Pain Pract. 2010;10:416-27. [PMID: 20602712] doi: 10.1111/j.1533-2500.2010.00397.x
52. Mitra F, Chowdhury S, Shelley M, Williams G. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain. Pain Med. 2013;14:75-83. [PMID: 23320402] doi: 10.1111/pme.12011
53. Krebs EE, Becker WC, Zerzan J, Bair MJ, McCoy K, Hui S. Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain. Pain. 2011;152:1789-95. [PMID: 21524850] doi: 10.1016/j.pain.2011.03.023
54. Hartung DM, Middleton L, Haxby DG, Koder M, Ketchum KL, Chou R. Rates of adverse events of long-acting opioids in a state Medicaid program. Ann Pharmacother. 2007;41:921-8. [PMID: 17504834]
55. Naliboff BD, Wu SM, Schieffer B, Bolus R, Pham Q, Baria A, et al. A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain. J Pain. 2011;12:288-96. [PMID: 21111684] doi: 10.1016/j.jpain.2010.09.003
56. Cowan DT, Wilson-Barnett J, Griffiths P, Vaughan DJ, Gondhia A, Allan LG. A randomized, double-blind, placebo-controlled, crossover pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine. Pain Med. 2005;6: 113-21. [PMID: 15773875]
57. Ralphs JA, Williams AC, Richardson PH, Pither CE, Nicholas MK. Opiate reduction in chronic pain patients: a comparison of patientcontrolled reduction and staff controlled cocktail methods. Pain. 1994;56:279-88. [PMID: 8022621]
58. Tennant FS Jr, Rawson RA. Outpatient treatment of prescription opioid dependence: comparison of two methods. Arch Intern Med. 1982;142:1845-7. [PMID: 6181749]
59. Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage. 2006;32:287-93. [PMID: 16939853]
60. Jones T, Moore T, Levy JL, Daffron S, Browder JH, Allen L, et al. A comparison of various risk screening methods in predicting discharge from opioid treatment. Clin J Pain. 2012;28:93-100. [PMID: 21750461] doi: 10.1097/AJP.0b013e318225da9e
61. Moore TM, Jones T, Browder JH, Daffron S, Passik SD. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management. Pain Med. 2009;10:1426-33. [PMID: 20021601] doi: 10.1111/j.1526-4637.2009.00743.x
62. Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432-42. [PMID: 16336480]
63. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010:CD006605. [PMID: 20091598] doi: 10.1002/14651858.CD006605.pub2
64. Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton- Kehoe D. Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med. 2012;55:325-31. [PMID: 22213274] doi: 10.1002/ajim.21998
65. U.S. Food and Drug Administration. Public Health Advisory: Important Information for the Safe Use of Fentora (fentanyl buccal tablets). Silver Spring, MD: U.S. Food and Drug Administration; 2013.
66. Chou R, Cruciani RA, Fiellin DA, Compton P, Farrar JT, Haigney MC, et al. Methadone safety: a clinical practice guideline from the American Pain Society and College on Problems of Drug Dependence, in collaboration with the Heart Rhythm Society. J Pain. 2014; 15:321-37. [PMID: 24685458] doi: 10.1016/j.jpain.2014.01.494
67. Jones T, Moore T. Preliminary data on a new opioid risk assessment measure: the Brief Risk Interview. J Opioid Manag. 2013;9:19- 27. [PMID: 23709300] doi: 10.5055/jom.2013.0143
68. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315-21. [PMID: 21467284] doi: 10.1001/jama.2011.370
69. Paulozzi LJ, Kilbourne EM, Shah NG, Nolte KB, Desai HA, Landen MG, et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med. 2012;13:87-95. [PMID: 22026451] doi: 10.1111/j.1526-4637.2011.01260.x
70. Byas-Smith MG, Chapman SL, Reed B, Cotsonis G. The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clin J Pain. 2005;21:345-52. [PMID: 15951653]
71. Gaertner J, Frank M, Bosse B, Sabatowski R, Elsner F, Giesecke T, et al. [Oral controlled-release oxycodone for the treatment of chronic pain. Data from 4196 patients]. Schmerz. 2006;20:61-8. [PMID: 15926076]
72. Galski T, Williams JB, Ehle HT. Effects of opioids on driving ability. J Pain Symptom Manage. 2000;19:200-8. [PMID: 10760625]
73. Sabatowski R, Schwalen S, Rettig K, Herberg KW, Kasper SM, Radbruch L. Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage. 2003;25:38-47. [PMID: 12565187]
74. Menefee LA, Frank ED, Crerand C, Jalali S, Park J, Sanschagrin K, et al. The effects of transdermal fentanyl on driving, cognitive performance, and balance in patients with chronic nonmalignant pain conditions. Pain Med. 2004;5:42-9. [PMID: 14996236]
75. Deyo RA, Smith DH, Johnson ES, Donovan M, Tillotson CJ, Yang X, et al. Opioids for back pain patients: primary care prescribing patterns and use of services. J Am Board Fam Med. 2011;24:717-27. [PMID: 22086815] doi: 10.3122/jabfm.2011.06.100232
76. Mailis-Gagnon A, Lakha SF, Ou T, Louffat A, Yegneswaran B, Umana M, et al. Chronic noncancer pain: characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic. Can Fam Physician. 2011;57:e97-105. [PMID: 21402957]
77. Seal KH, Shi Y, Cohen G, Cohen BE, Maguen S, Krebs EE, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307:940-7. [PMID: 22396516] doi: 10.1001/jama.2012.234
78. O'Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, et al. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain. 2013;154:2324-34. [PMID: 24148704] doi: 10.1016/j.pain.2013.06.035